குறைந்த செலவு ஜெநெரிக் இரும்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
ResearchAndMarkets.com s offering.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021-2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence of iron deficiency (ID). This deficiency is a highly widespread nutritional disorder, affecting around one-fourth of the global population, especially women and children. It is one of the predominant causes of anemia. Anemia accounts for around 9% of the total global disease burden. Several chronic diseases are frequently associated with iron deficiency anemia (IDA) such as chronic kidney disease (CKD), chronic heart failure, cancer, and inflammatory bowel diseases. As anemia is associated with chronic fatigue, diminished well-being, and impaired cognitive functi ....

United States , United Kingdom , South Africa , Saudi Arabia , South Korea , Vifor Pharma , Laura Wood , Combination Dietary Supplements Nutritional Health Products , Daiichi Sankyo Company , Ciron Drugs Pharmaceuticals , Office Hours Call , Research Methodology , Administration Segmentation , Patient Group , Key Company Profiles , E St Office Hours Call , Patient Group Segmentation , Route Of Administration Segmentation , Research Objectives , Route Of Administration , Oral Iron Drugs Market , Data Driven Insights , Oral Iron Drugs , Branded Iron Therapeutics , Expanded Indication , Topics Covered ,